SEP 29, 2026 · JOURNAL ARTICLE
The Immune Checkpoint Inhibitors Journey: From Early Promise to Lasting Impact
Journal of Immunotherapy and Precision Oncology
ABSTRACT Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, yet their clinical impact is limited by immune-related adverse events (irAEs), therapeutic resistance,